Assessing the independent and combined effects of subsidies for antimalarials and rapid diagnostic testing on fever management decisions in the retail sector: Results from a factorial randomised trial in western Kenya

BMJ Global Health

Volumn 1, Issue 2, 2016, Pages

  O'Meara, Wendy Prudhomme ^a,b,c   Mohanan, Manoj ^b,d   Laktabai, Jeremiah ^c,e   Lesser, Adriane ^b   Platt, Alyssa ^b   Maffioli, Elisa ^b,d   Turner, Elizabeth L ^b   Menya, Diana ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOI UNIVERSITY   (Kenya)

^d DUKE UNIVERSITY   (United States)

^e ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85032044769     PISSN: None     EISSN: 20597908     Source Type: Journal    
DOI: 10.1136/bmjgh-2016-000101     Document Type: Article

References (22)

1. Adeyi O, Atun R. Innovating for impact: the Affordable Medicines Facility-malaria (AMFm). Nat Med 2009;15:991.
2. Tougher S, Ye Y, Amuasi JH, et al. Effect of the Affordable Medicines Facility - malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet 2012;380:1916-26.
3. Cohen J, Dupas P, Schaner S. Price subsidies, diagnostic tests, and targeting of malaria treatment: evidence from a randomized controlled trial. Am Econ Rev 2015;105:609-45.
4. Briggs MA, Kalolella A, Bruxvoort K, et al. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies. PLoS ONE 2014;9:e94074.
5. Mbonye AK, Lal S, Cundill B, et al. Treatment of fevers prior to introducing rapid diagnostic tests for malaria in registered drug shops in Uganda. Malar J 2013;12:131.
6. Adhvaryu A. Learning, misallocation, and technology adoption: evidence from new malaria therapy in Tanzania. Rev Econ Stud 2014;81:1331-65.
7. Dupas P. Getting essential health products to their end users: subsidize, but how much? Science 2014;345:1279-81.
8. Okeke EN, Adepiti CA, Ajenifuja KO. What is the price of prevention? New evidence from a field experiment. J Health Econ 2013;32:207-18.
9. Wang D, Bakhai A. Clinical trials: a practical guide to design, analysis, and reporting. Remedica, 2006.
10. Kolenikov S, Angeles G. The Use of Discrete Data in PCA: Theory, Simulations and Applications to Socioeconomic Indices. CPC/MEASURE 2004;working paper number. WP-04-85.
11. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Demography 2001;38:115-32.
12. Akaike H. A new look at the statistical model identification. Autom Control, IEEE Transactions on 1974;19:716-23.
13. Das J, Hammer J, Sánchez-Paramo C. The impact of recall periods on reported morbidity and health seeking behavior. J Dev Econ 2012;98:76-88.
14. Cohen J, Dupas P, Schaner S. Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial. National Bureau of Economic Research 2012; working paper 17943.
15. Mangham LJ, Cundill B, Achonduh OA, et al. Malaria prevalence and treatment of febrile patients at health facilities and medicine retailers in Cameroon. Trop Med Int Health 2012;17:330-42.
16. Briggs M, Kalolella A, Bruxvoort K, et al. Prevalence of malaria parasitemia and medication utilization patterns among clients seeking care for malaria or fever in drug shops in Tanzania, March - May 2012. Annual Meeting of the American Society of Tropical Medicine and Hygiene 2012;abstract.
17. Cohen J, Fink G, Maloney K, et al. Introducing rapid diagnostic tests for malaria to drug shops in Uganda: a cluster-randomized controlled trial. Bull World Health Organ 2015;93:143-51.
18. Mbonye AK, Ndyomugyenyi R, Turinde A, et al. The feasibility of introducing rapid diagnostic tests for malaria in drug shops in Uganda. Malar J 2010;9:367.
19. Mbonye AK, Magnussen P, Lal S, et al. A cluster randomised trial introducing rapid diagnostic tests into registered drug shops in Uganda: impact on appropriate treatment of malaria. PLoS ONE 2015;10:e0129545.
20. Ansah EK, Narh-Bana S, Affran-Bonful H, et al. The impact of providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: a cluster randomized trial. BMJ 2015;350:h1019.
21. Isiguzo C, Anyanti J, Ujuju C, et al. Presumptive treatment of malaria from formal and informal drug vendors in Nigeria. PLoS ONE 2014;9:e110361.
22. Cohen J, Fink G, Berg K, et al. Feasibility of distributing rapid diagnostic tests for malaria in the retail sector: evidence from an implementation study in Uganda. PLoS ONE 2012;7:e48296.